(NASDAQ: MDWD) Mediwound's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 10.6%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.33%.
Mediwound's earnings in 2025 is -$21,221,000.On average, 4 Wall Street analysts forecast MDWD's earnings for 2025 to be -$21,515,649, with the lowest MDWD earnings forecast at -$24,836,131, and the highest MDWD earnings forecast at -$13,929,830. On average, 5 Wall Street analysts forecast MDWD's earnings for 2026 to be -$23,950,669, with the lowest MDWD earnings forecast at -$32,178,988, and the highest MDWD earnings forecast at -$17,277,309.
In 2027, MDWD is forecast to generate -$20,408,821 in earnings, with the lowest earnings forecast at -$30,775,206 and the highest earnings forecast at -$14,469,746.